') no-repeat 50% 50%;mask:url('data:image/svg+xml, ') no-repeat 50% 50%;-webkit-mask-size:cover;mask-size:cover;margin-left:.625rem;transform:rotate(0);transition:transform .1s}.dropdown-toggle:not([class*=btn-]):focus,.dropdown-toggle:not([class*=btn-]):hover{color:#2196f3;font-weight:500;background-color:inherit}.form-control{height:calc(1.6568em + 1.25rem + 2px);background-clip:border-box;-webkit-appearance:none;filter:none}.form-control:-webkit-autofill,.form-control:-webkit-autofill:active,.form-control:-webkit-autofill:focus,.form-control:-webkit-autofill:hover{box-shadow:0 0 0 30px #fff inset!important}.form-control:disabled{color:#999;background-color:#f5f5f5}.form-control,.form-control:focus,.form-control:focus-visible{box-shadow:none}.input-group-sm .form-control{height:2.10419375rem}.form-check-new{position:relative;display:flex}.form-check-new+.form-check-new{margin-top:.625rem}.form-check-new:not(.inline){margin-bottom:.25rem}.form-check-new:not(.inline)>xetf-checkbox{margin-right:.875rem}.text-check{line-height:1.5;font-size:.75rem;color:#444;padding-top:1px}.text-check.sm{font-size:.625rem;padding-top:2px}.text-check a{font-weight:600}.check-container{display:flex;align-items:center;margin-bottom:0;cursor:pointer}.check-container:not(.disabled):hover{color:#666}.check-container .checkbox,.check-container .checkbox input,.check-container .checkbox span{width:var(--checkbox-size);height:var(--checkbox-size)}.check-container .checkbox input{border:0;background:0 0;display:inline-block;margin:0;cursor:pointer;position:absolute;visibility:visible;opacity:0;z-index:2}.check-container .checkbox input:checked~span:after{opacity:1}.check-container .checkbox input:focus~span,.check-container .checkbox input:hover~span{box-shadow:0 4px 4px #0000001f}.check-container .checkbox span{display:inline-block;position:relative;text-align:center;border-style:solid;border-color:#999;color:#42a5f5;transition:box-shadow .15s ease-in}.check-container .checkbox span:after{content:"";position:absolute;opacity:0;transition:opacity .15s ease-in}.check-container .checkbox span:checked:after{opacity:1}.fs-sm{font-size:.8125rem!important}.fs-xs{font-size:.75rem!important}.fs-larger{font-size:larger}.cursor-pointer{cursor:pointer}.w-100{width:100%!important}.hidden{visibility:hidden}.nowrap{white-space:nowrap}.input-group{margin-bottom:1.25rem}.input-group .form-control::placeholder{color:#aaa;font-weight:500}.input-group .form-control::-webkit-search-cancel-button{display:none}.input-group .form-control::-webkit-inner-spin-button,.input-group .form-control::-webkit-outer-spin-button{-webkit-appearance:none;margin:0}.input-group:focus-within .input-group-text{border-color:#999}.input-group-text{font-weight:500;transition:border-color .15s ease-in-out,box-shadow .15s ease-in-out}.input-group-text xetf-icon{color:#bbb;font-size:.9375rem;z-index:4}.input-group-text:first-child{border-right:0;border-top-right-radius:0;border-bottom-right-radius:0}.input-group-text+.form-control{border-left:0}.input-group-text+.form-control{padding-left:0}.input-group-text+.form-control:disabled{border-left-width:0;padding-left:2.625rem!important;margin-left:-2.625rem!important}html{display:flex;flex-direction:column;scroll-behavior:smooth}body{min-height:100vh;display:flex;flex-direction:column;flex:1}.content{padding:1.25rem .625rem;flex-grow:1;z-index:1}app-root{transition:.15s ease-in}.nav-link{position:relative;transition:.15s ease-in-out}.nav-pills{--bs-nav-pills-border-radius:5px;--bs-nav-pills-link-active-color:#fff;--bs-nav-pills-link-active-bg:#2196f3;margin-bottom:1.25rem}.nav-pills .nav-link{color:#777}.nav-pills .nav-link:not(.active):focus,.nav-pills .nav-link:not(.active):hover{color:#324148}.toolbar-container{display:flex;flex-wrap:wrap;position:relative}.toolbar-container .toolbar-main-items,.toolbar-container .toolbar-misc-items{height:40px}.toolbar-container .toolbar-main-items{position:static;overflow-x:auto;overflow-y:hidden;flex:1 0 100%}.toolbar-container .toolbar-main-items:after,.toolbar-container .toolbar-main-items:before{content:"";position:absolute;top:0;width:30px;height:40px;z-index:1;transition:box-shadow .3s;pointer-events:none}.toolbar-container .toolbar-main-items:before{left:0}.toolbar-container .toolbar-main-items:after{right:0}.toolbar-container .toolbar-main-items::-webkit-scrollbar{display:none}.toolbar-container .toolbar-misc-items{position:relative;display:flex;flex-wrap:nowrap;flex-grow:1}.toolbar-container .border-placeholder{position:absolute;left:0;right:0;top:38px;height:2px;background-color:#e5e5e5}.toolbar-container .nav-pills{justify-content:space-between;flex-wrap:nowrap;margin-bottom:0}.toolbar-container .nav-pills>:not(.separator){text-align:center;flex:1}.toolbar-container .separator{position:relative}.toolbar-container .separator:after{content:"";position:absolute;height:14px;width:1px;right:1px;border-right:1px solid #c9c9c9;top:calc(50% - 7px)}.toolbar-container .nav-link{position:relative;white-space:nowrap;-webkit-user-select:none;user-select:none;line-height:20px;padding:10px 20px;color:#333;border-radius:0}.toolbar-container .nav-link:focus,.toolbar-container .nav-link:hover{color:#2196f3!important}.toolbar-container .nav-link.active{color:#2196f3!important;background-color:transparent!important}.toolbar-container .nav-link.active:after{content:"";position:absolute;bottom:0;left:0;right:0;height:4px;background-color:#2196f3;z-index:2}.new-navbar-collapse{position:absolute;inset:2.25rem 0 auto!important;z-index:600;padding:1.25rem 0;background-color:#324148;transform:translateY(-520px);will-change:transform;transition:transform .3s ease-in}.new-navbar-collapse .dropdown-menu{overflow:hidden}.navbar{font-size:.75rem;font-weight:600}.navbar .dropdown-item,.navbar .dropdown-menu,.navbar .dropdown-toggle,.navbar .navbar-nav-link{font-size:.75rem;white-space:nowrap}.navbar .dropdown-toggle:hover{font-weight:600}.navbar .nav-item>a{position:relative}.navbar-brand img{height:1.625rem;display:block}.navbar-nav{justify-content:space-evenly}.navbar-nav-link{position:relative;display:flex;cursor:pointer;padding:1rem 1.75rem;outline:0;transition:.15s ease-in-out}.navbar-toggler{z-index:601;border:0;cursor:pointer;padding:.75rem 5px;transition:.15s ease-in-out}.navbar-toggler:last-child{margin-left:5px;margin-right:-10px}@media (max-width:1199.98px){.navbar-brand img{height:1.25rem}.navbar-expand-xl .navbar-nav-link.dropdown-toggle:after{position:absolute;right:calc(1.5rem + 7px);margin:0}.navbar-expand-xl .navbar-nav>.nav-item>.dropdown-menu{width:100%;border-radius:0}}.navbar-dark{--bs-navbar-color:#fff;--bs-navbar-hover-color:#fff;--bs-navbar-disabled-color:rgba(255, 255, 255, .5);--bs-navbar-active-color:#fff;--bs-navbar-brand-color:#fff;--bs-navbar-brand-hover-color:#fff;--bs-navbar-toggler-border-color:rgba(255, 255, 255, .1);--bs-navbar-toggler-icon-bg:url("data:image/svg+xml,%3csvg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 30 30'%3e%3cpath stroke='%23fff' stroke-linecap='round' stroke-miterlimit='10' stroke-width='2' d='M4 7h22M4 15h22M4 23h22'/%3e%3c/svg%3e");color:#fff;background-color:#324148}.navbar-dark .navbar-nav-link{color:#fff;padding:1rem}.navbar-dark .navbar-nav-link:focus,.navbar-dark .navbar-nav-link:hover{color:#fff;background-color:#00000026}.table{margin-bottom:0;color:#324148}.table td,.table th{vertical-align:middle;padding-left:2px;padding-right:2px}.table th{font-weight:500}.table thead th{vertical-align:middle;border-bottom:2px solid #e5e5e5}.table>:not(:first-child){border-top:0}.table tbody tr:last-child>*{border-bottom-width:0}.table.last-column-end td:last-child,.table.last-column-end th:last-child{text-align:right}h1,h2,h3{letter-spacing:-.015em;font-weight:700}.text-default{color:#324148!important}a.text-default:not(.btn):not(.td_btn):not(.vc_btn){transition:color .15s ease-in-out}a.text-default:focus,a.text-default:hover{color:#324148bf}.toolbar-main-items{overflow-x:auto;overflow-y:hidden}.toolbar-main-items::-webkit-scrollbar{height:0}.toolbar-main-items:after,.toolbar-main-items:before{content:"";position:absolute;top:0;bottom:0;width:30px;z-index:1;transition:box-shadow .3s;pointer-events:none}.toolbar-main-items:before{left:0}.toolbar-main-items:after{right:0}.profile-card h1{font-size:1.875rem;font-weight:700;margin-bottom:0;line-height:1}@media (max-width:767.98px){.profile-card{margin-bottom:1rem}.profile-card h1{font-size:1.25rem}.profile-card .top-info.desktop-only{display:none}}.profile-card .card-body{padding-bottom:0}.profile-card .profile-main-info{display:flex;flex-wrap:wrap;align-items:center;font-size:.625rem}.profile-card .profile-main-info.with-bottom-space>*{margin-bottom:1.125rem}.profile-card .profile-main-info .badge.badge-light{padding-top:7px;padding-bottom:7px}.profile-card .separated-properties>button:not(:first-child):not(:empty):not(.badge):before,.profile-card .separated-properties>span:not(:first-child):not(:empty):not(.badge):before{content:"|";color:#c9c9c9;margin-left:.25rem;margin-right:.25rem}.profile-card .separated-properties>span.badge:not(:last-child){margin-right:.625rem!important}.profile-card .nav-pills{margin-bottom:1.125rem}.profile-card .top-info{display:flex;flex-wrap:wrap;min-width:150px}.profile-card .top-info .top-info-column{position:relative;margin-bottom:1.125rem}.profile-card .top-info .top-info-column>.text-muted{display:flex;align-items:center;white-space:nowrap}.profile-card .top-info .top-info-column:not(:last-child){padding-right:1.25rem;margin-right:1.25rem}.profile-card .top-info .top-info-column:not(:last-child):after{content:"";position:absolute;height:14px;width:1px;right:1px;border-right:1px solid #c9c9c9;top:calc(50% - 7px);padding:0 1.25rem}.profile-card .top-info .value{font-size:.875rem;line-height:130%;font-weight:700}.profile-card .top-info .text-muted{font-size:.625rem}.profile-card .top-info .text-muted>xetf-icon{margin-left:.3125rem;color:#1976d2}.profile-card .provider-icon-wrapper{display:flex;align-items:flex-start;margin-bottom:.625rem}.profile-card .provider-icon-wrapper .provider-logo{display:block}.profile-card .provider-icon-wrapper .provider-logo{height:50px;min-width:50px;overflow:hidden;margin:0 1.25rem auto 0}.profile-card .provider-icon-wrapper .investment-name-wrapper{display:flex;flex-direction:column}.profile-card .provider-icon-wrapper .investment-name-wrapper .investment-name{display:flex;flex-direction:row}.profile-card .provider-icon-wrapper .investment-name-wrapper xetf-icon{color:#1976d2}.profile-card .toolbar-container{border-top:2px solid #e5e5e5}.profile-card .toolbar-container .toolbar-main-items{border-bottom-left-radius:5px}.profile-card .toolbar-container.with-misc-items .toolbar-main-items .nav-item .nav-link{padding-left:14px;padding-right:14px}@media (max-width:767.98px){.profile-card .toolbar-container.with-misc-items .toolbar-main-items .nav-item .nav-link{min-width:calc((100vw - 1.25rem)/ 3)}}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items{justify-content:space-evenly}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items>:not(.separator){padding-left:1.75rem;padding-right:1.75rem}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items xetf-icon{display:block}.profile-card .border-placeholder{display:none}a>xetf-icon{margin-bottom:2px}.app-container{width:100%;margin:0 auto}a{cursor:pointer}.auth-offer-container{position:relative;display:block;min-height:150px}.btn-product-stock{background:0 0;color:inherit;border:none;padding:0;font:inherit;cursor:pointer;outline:inherit;white-space:nowrap;line-height:2}.btn-product-stock xetf-icon{color:inherit!important;margin-bottom:2px}.course-value{font-size:1.625rem;font-weight:700;margin-bottom:0;margin-right:1.5rem}.course-percentage{font-size:1rem;font-weight:700}.card-columns-ordered>*{page-break-inside:avoid!important;break-inside:avoid!important}
Bitte Javascript aktivieren CRISPR Therapeutics AG C
CRISPR Therapeutics AG Aktie ISIN: CH0334081137 WKN: A2AT0Z Ticker: 1CG Biotechnologie Biotechnologie
3,15 Mrd. € Marktkapitalisierung Kurs, Beschreibung, Chart, Renditen, Kennzahlen CRISPR Therapeutics AG Aktienkurs
Die CRISPR Therapeutics AG Aktie ist aktuell bei keinem Online Broker sparplanfähig.
Wichtige Kennzahlen und Stammdaten zur CRISPR Therapeutics AG Aktie.
3,15 Mrd. € KGV — KBV — KUV 1.666,67 KCV — Ausgegebene Aktien 79 Mio. Stück
Die CRISPR Therapeutics AG ist ein Gen-Editing-Unternehmen. Es beschäftigt sich mit der Entwicklung von CRISPR/Cas9-basierten Therapeutika. CRISPR/Cas9 ist eine Technologie, die präzise, gezielte Veränderungen der genomischen DNA ermöglicht. Die fortgeschrittenen Programme des Unternehmens zielen auf Beta-Thalassämie und Sichelzellkrankheit ab, zwei Hämoglobinopathien mit hohem medizinischem Bedarf.
CRISPR Therapeutics AG ist in folgendem Land registriert: Schweiz (Börse: USNASD).
Hier siehst du die Wertentwicklung der CRISPR Therapeutics AG Aktie.
Zeitraum Performance 1 Woche -100,00 % 1 Monat -100,00 % 3 Monate -100,00 % 6 Monate -100,00 % 1 Jahr -100,00 % Lfd. Jahr -100,00 %
Mit einer (erwarteten) Jahresdividende von — ergibt sich zum aktuellen Kurs der Aktie eine Dividendenrendite von —.
Dividendenart — (Erwartete) Jahresdividende — Dividendenrendite —
Stammdaten werden bereitgestellt von Morningstar (Aktien, ETFs, Fonds), CoinGecko (Kryptowährungen) und der Isarvest GmbH. Kursdaten sind mindestens 15 Minuten zeitverzögerte Börsenkurse (Aktien, ETFs, Fonds) oder NAV-Kurse (ETFs, Fonds). Realtime-Kurse – sofern verfügbar – stammen von den Anbietern und der Lang & Schwarz (Aktien, ETFs, Fonds) und CoinGecko (Kryptowährungen).
Die Isarvest GmbH übernimmt für die dargestellten Informationen keine Gewährleistung und kann nicht sicherstellen, dass die Daten vollständig und genau sind.
Affiliate Hinweis * Bei den mit Sternchen (*) gekennzeichneten Links handelt es sich um Werbe- oder Affiliate-Links. Wenn du über diesen Link etwas kaufst oder abschließt, erhalten wir eine Vergütung des Anbieters. Dir entstehen dadurch keine Nachteile oder Mehrkosten. Wir verwenden diese Einnahmen, um unser kostenfreies Angebot zu finanzieren. Vielen Dank für deine Unterstützung.